Market SizeThe global Gamma Valerolactone market was valued at US$ 766.6 million in 2022 and is projected to decline to US$ 751.3 million by 2029, reflecting a Compound Annual Growth Rate (CAGR) of -0.3% over the forecast period. The slight market contraction can be attributed to geopolitical factors such as the COVID-19 pandemic and the Russia-Ukraine War, both of which have disrupted supply ch..